Search results for "Perspectives"
Chapter advocacy key to advancing ACP's priorities
ACP's legislative staff are following four key court cases on affirmative action, gun violence, climate change, and women's reproductive health care rights.
https://immattersacp.org/archives/2022/06/chapter-advocacy-key-to-advancing-acps-priorities.htm
1 Jun 2022
ATS/IDSA release clinical practice guideline on diagnosing, treating CAP
The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019
New research on booster doses, breakthrough infections, long-term COVID-19 symptoms
A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021
MKSAP Quiz: 3-year history of knee stiffness
A 58-year-old man is evaluated for a 3-year history of left knee stiffness, which was intermittent but has become more persistent in the past 4 months. He reports no daily pain but has knee stiffness for 10 minutes in the morning and when he sits for an extended period of time. Following a physical exam and radiograph, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/11/17/3.htm
17 Nov 2020
NSAIDs associated with increased risk of bleeding, cardiovascular events after MI
Compared to other NSAIDs, celecoxib and meloxicam were associated with a lower risk of bleeding or cardiovascular events among Korean patients who had a myocardial infarction (MI).
https://immattersacp.org/weekly/archives/2020/07/28/5.htm
28 Jul 2020
Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging
An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021
The road to advocacy's ‘Final Four’
Although ACP achieved major changes to the evaluation and management (E/M) codes, implementation of these changes has not been perfect. There is ongoing work to be done.
https://immattersacp.org/archives/2023/03/the-road-to-advocacys-final-four.htm
1 Mar 2023
Weighing benefits, harms of cannabis
Marijuana use has risen, so internists need to understand its real risks as well as its potential clinical uses, such as for chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity symptoms.
https://immattersacp.org/archives/2019/04/weighing-benefits-harms-of-cannabis.htm
1 Apr 2019
Internal medicine takes San Diego by storm
This issue features coverage of Internal Medicine Meeting 2023.
https://immattersacp.org/archives/2023/07/internal-medicine-takes-san-diego-by-storm.htm
1 Jul 2023
Personal choices may sway mammography
Primary care physicians who raise the subject of breast cancer screening with their patients may discover that they approach this decision from a different perspective.
https://immattersacp.org/archives/2021/10/personal-choices-may-sway-mammography.htm
1 Oct 2021